90Y-IBRITUMOMAB Tiuxetan and AHCI With HD Chemotherapy and Autologous Transplantation for Relapsed or Resistant NHL
Completed · Phase 1
Conditions studied: Lymphoma, Non-Hodgkin, Blood and Marrow Transplant (BMT)
In brief
To test a new way to approach hematopoietic stem cell transplantation for Relapsed or Resistant Non-Hodgkin's Lymphoma.
Key facts
- Study ID
- NCT00186589
- Run by
- Stanford University
- People needed
- 30
- Starts
- 2004-05-01
- Expected to finish
- 2007-07-01
- Last updated by the study team
- 2012-06-06
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Stanford University School of Medicine — Stanford, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.